oral enteric coated imatinib (Tenax Therapeutics)

口服肠溶伊马替尼 (Tenax Therapeutics)

Report date: 2024/03/04 17:50:34

Base Information

Drug Nameoral enteric coated imatinib (Tenax Therapeutics)
Drug Alias NameTNX-201 (Tenax Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitorsBcr-Abl tyrosine kinase inhibitorsPlatelet-derived growth factor receptor inhibitors
TargetsStem cell growth factor receptorBcr-Abl tyrosine kinasePlatelet-derived growth factor receptor
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPH Precision Med
China Registration ClassN/A

Develop Information

Active CompaniesTenax Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A